Generation of Humanized Mice Susceptible to Peptide-Induced Inflammatory Heart Disease
- 13 April 1999
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 99 (14) , 1885-1891
- https://doi.org/10.1161/01.cir.99.14.1885
Abstract
Background−Dilated cardiomyopathy (DCM) is a major cause of sudden cardiac death. In certain mouse major histocompatibility complex (MHC) backgrounds, myocarditis and inflammatory cardiomyopathy can be triggered by immunization with heart muscle–specific proteins. Similarly, chronic heart disease in humans has been linked to certain HLA alleles, such as HLA-DQ6. However, there is no experimental evidence showing that human MHC class II molecules and peptides derived from human proteins are involved in the pathogenesis of myocarditis and DCM.Methods and Results—We generated double CD4- and CD8-deficient mice transgenic for human CD4 (hCD4) and human HLA-DQ6 to specifically reconstitute the human CD4/DQ6 arm of the immune system in mice. Transgenic hCD4 and HLA-DQ6 expression rendered genetically resistant C57BL/6 mice susceptible to the induction of autoimmune myocarditis induced by immunization with cardiac myosin. Moreover, we identified heart-specific peptides derived from both mouse and human α-myosin heavy chains capable of inducing inflammatory heart disease in hCD4 and HLA-DQ6 double transgenic mice but not in hCD4 single transgenic littermates. The autoimmune inflammatory heart disease induced by the human heart muscle–specific peptide in hCD4 and HLA-DQ6 double transgenic mice shared functional and phenotypic features with the disease occurring in disease-susceptible nontransgenic mice.Conclusions—Our data provide the first genetic and functional evidence that human MHC class II molecules and a human α-myosin heavy chain–derived peptide can cause inflammatory heart disease and suggest that human inflammatory cardiomyopathy can be caused by organ-specific autoimmunity. The humanized mice generated in this study will be an ideal animal model to further elucidate the pathogenesis of inflammatory heart disease and facilitate the development of rational treatment strategies.Keywords
This publication has 30 references indexed in Scilit:
- Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relativesInternational Journal of Cardiology, 1996
- Possible involvement of the HLA-DQB1 gene in susceptibility and resistance to human dilated cardiomyopathyAmerican Heart Journal, 1995
- HLA and immunoglobulin polymorphisms in idiopathic dilated cardiomyopathyHuman Immunology, 1992
- Characterization of the allelic differences in the mouse cardiac α-myosin heavy chain coding sequenceGenomics, 1992
- Complete sequence of human cardiac α‐myosin heavy chain gene and amino acid comparison to other myosins based on structural and functional differencesAmerican Journal of Medical Genetics, 1991
- Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4Nature, 1991
- Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: A nonhistologic marker of myocarditisJournal of the American College of Cardiology, 1990
- Idiopathic cardiomyopathy in the United States, 1970–1982American Heart Journal, 1986
- HLA A, B and DR typing in idiopathic dilated cardiomyopathy: A search for immune response factorsThe American Journal of Cardiology, 1984
- Cell-mediated immune responsiveness to cardiac extracts by peripheral blood leukocytes from patients after myocardial infarction or open-heart surgeryClinical Immunology and Immunopathology, 1984